Research
Viscoelasticity of synthetic antigen presenting cells reprograms T cell metabolism for TCR-T cell manufacturing and therapy
Nature · By Youcheng Yang ·
The Brief
- Published online in Nature Communications on 20 November 2026 (doi:10.1038/s41467-026-78131-6).
- Builds on earlier work by Li and colleagues on viscoelastic synthetic antigen-presenting cells for CAR-T therapy.
- Reports that fast-relaxing synthetic antigen-presenting cells reprogram T cell metabolism, with relevance to TCR-T cell manufacturing and therapy.
Why it matters
It suggests that the mechanical properties of artificial cells used to activate T cells can change the T cells' metabolism, which could matter for how cell therapies are manufactured.
Who’s affected
- immunologists and cell therapy researchers
- biomedical engineers working on T cell manufacturing
- #t cell metabolism
- #cell therapy
- #viscoelasticity
- #tcr-t
- #antigen-presenting cells
- #immunotherapy
Nature Communications, Published online: 20 November 2026; doi:10.1038/s41467-026-78131-6 Li and colleagues have previously reported the generation of viscoelastic synthetic antibody-presenting cells for CAR-T therapy. Here the authors report that fast-relaxing synthetic…